CMS issues FAQs on legislations’ COVID-19 Medicaid/CHIP provisions
The Centers for Medicare & Medicaid Services this week issued guidance implementing legislative provisions specific to enhanced federal funding for Medicaid and Children’s Health Insurance Program, as well as a new state Medicaid option to cover COVID-19 diagnostic testing and services for the uninsured, as authorized by the Families First Coronavirus Response Act and the Coronavirus Aid, Relief, and Economic Security Act. The guidance is in the form of frequently asked questions.
Related News Articles
Headline
Adults age 65 and older are encouraged to receive an updated dosage of the COVID-19 vaccine, the Centers for Disease Control and Prevention announced April 25…
Headline
The Centers for Medicare & Medicaid Services April 19 approved an amendment to a Massachusetts Medicaid and Children’s Health Insurance Program…
Headline
The Pfizer and Moderna COVID-19 vaccines can cause myocarditis, but do not appear to cause infertility, Guillain-Barré syndrome, Bell’s palsy, thrombosis with…
Headline
The Centers for Medicare & Medicaid Services March 28 announced an extension of its temporary Marketplace special enrollment period for those who lost…
Headline
The Centers for Medicare & Medicaid Services March 27 finalized a rule proposed in 2022 to standardize Medicaid and CHIP enrollment and renewal processes…
Headline
The Centers for Medicare & Medicaid Services March 7 invited drug makers in the Medicaid Drug Rebate Program that make federally approved gene therapies…